via HIV Prevention Trials Network
HPTN 071
The PopART Study
The HIV Prevention Trials Network (HPTN) is delighted to announce a new study, PopART, (HPTN 071), which will examine the impact of a combination prevention strategy, including early antiretroviral therapy (ART), on population level HIV incidence in Zambia and South Africa. Partners for this study include the London School of Hygiene and Tropical Medicine, Imperial College, London, the Zambia AIDS Related Tuberculosis Project (ZAMBART), and the Desmond Tutu TB Centre (DTTC).
HPTN 071 is a natural extension of HPTN’s robust HIV prevention research and will build upon the network’s groundbreaking studies. The primary objective of HPTN 071 is to evaluate a prevention package utilizing a combination of interventions includ-ing voluntary testing, counseling and antiretroviral therapy (ART). The study is in line with the goals of the U.S. President’s Emer-gency Plan for AIDS Relief (PEPFAR) which aims to “expand its emphasis on HIV prevention, and matching interventions and investments with epidemiological trends and needs in order to improve impact.”
Read the rest.
[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position.]
HPTN 071
The PopART Study
The HIV Prevention Trials Network (HPTN) is delighted to announce a new study, PopART, (HPTN 071), which will examine the impact of a combination prevention strategy, including early antiretroviral therapy (ART), on population level HIV incidence in Zambia and South Africa. Partners for this study include the London School of Hygiene and Tropical Medicine, Imperial College, London, the Zambia AIDS Related Tuberculosis Project (ZAMBART), and the Desmond Tutu TB Centre (DTTC).HPTN 071 is a natural extension of HPTN’s robust HIV prevention research and will build upon the network’s groundbreaking studies. The primary objective of HPTN 071 is to evaluate a prevention package utilizing a combination of interventions includ-ing voluntary testing, counseling and antiretroviral therapy (ART). The study is in line with the goals of the U.S. President’s Emer-gency Plan for AIDS Relief (PEPFAR) which aims to “expand its emphasis on HIV prevention, and matching interventions and investments with epidemiological trends and needs in order to improve impact.”
Read the rest.
[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position.]
No comments:
Post a Comment